Analysis of the effects of anesthetics and ethanol on μ-Opioid receptor

Journal of Pharmacological Sciences

Volumn 112, Issue 4, 2010, Pages 424-431

  Minami, Kouichiro ^a,c   Sudo, Yuka ^b,c   Shiraishi, Seiji ^c   Seo, Masanori ^a   Uezono, Yasuhito ^c  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Ethanol; Ketamine; Xenopus oocyte; opioid receptor

Indexed keywords

ALCOHOL; ANESTHETIC AGENT; CALCIUM ION; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; HALOTHANE; KETAMINE; MU OPIATE RECEPTOR; PROPOFOL;

ANESTHESIA MECHANISM; ANIMAL CELL; ARTICLE; CHLORIDE CURRENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGY; FEMALE; NONHUMAN; OOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; XENOPUS LAEVIS;

EID: 77951235383     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10003FP     Document Type: Article

References (39)

1. Harper MH, Winter PM, Johnson BH, Eger EI 2nd. Naloxone does not antagonize general anesthesia in the rat. Anesthesiology. 1978;49:3-5.
2. Pace NL, Wong KC. Failure of naloxone and naltrexone to an-tagonize halothane anesthesia in the dog. Anesth Analg. 1979;58: 36-39.
3. Sarton E, Teppema LJ, Olievier C, Nieuwenhuijs D, Matthes HW, Kieffer BL, et al. The involvement of the mu-opioid recep-tor in ketamine-induced respiratory depression and antinocicep-tion. Anesth Analg. 2001;93:1495-1500.
4. Minami K, Uezono Y. Gq protein-coupled receptors as targets for anesthetics. Curr Pharm Des. 2006;12:1931-1937.
5. Durieux ME. Muscarinic signaling in the central nervous system. Recent developments and anesthetic implications. Anesthesiolo-gy. 1996;84:173-189.
6. Minami K, Gereau RW 4th, Minami M, Heinemann SF, Harris RA. Effects of ethanol and anesthetics on type 1 and 5 metabotro-pic glutamate receptors expressed in Xenopus laevis oocytes. Mol Pharmacol. 1998;53:148-156.
7. Minami K, Minami M, Harris RA. Inhibition of 5-hydroxy-tryptamine type 2A receptor-induced currents by n-alcohols and anesthetics. J Pharmacol Exp Ther. 1997;281:1136-1143.
8. Okamoto T, Minami K, Uezono Y, Ogata J, Shiraishi M, Shigematsu A, et al. The inhibitory effects of ketamine and pentobarbital on substance P receptors expressed in Xenopus oocytes. Anesth Analg. 2003;97:104-110.
9. Surratt CK, Adams WR. G protein-coupled receptor structural motifs: relevance to the opioid receptors. Curr Top Med Chem. 2005;5:315-324.
10. Minami K, Uezono Y, Ueta Y. Pharmacological aspects of the effects of tramadol on G-protein coupled receptors. J Pharmacol Sci. 2007;103:253-260.
11. Dascal N. The use of Xenopus oocytes for the study of ion channels. CRC Crit Rev Biochem. 1987;22:317-387.
12. Minami K, Uezono Y, Shiraishi M, Okamoto T, Ogata J, Horishita T, et al. Analysis of the effects of halothane on Gi-coupled mus-carinic M2 receptor signaling in Xenopus oocytes using a chimeric Gα protein. Pharmacology. 2004;72:205-212.
13. Hojo M, Sudo Y, Ando Y, Minami K, Takada M, Matsubara T, et al. μ-Opioid receptor forms a functional heterodimer with can-nabinoid CB1 receptor: electrophysiological and FRET assay analysis. J Pharmacol Sci. 2008;108:308-319.
14. + channels via Gαz and a receptor-Gαz fusion protein. Fusion be-tween the receptor and Gαz eliminates catalytic (collision) coupling. J Biol Chem. 2000;275:4166-4170.
15. Minami K, Vanderah TW, Minami M, Harris RA. Inhibitory effects of anesthetics and ethanol on muscarinic receptors expressed in Xenopus oocytes. Eur J Pharmacol. 1997;339:237-244.
16. Dildy-Mayfield JE, Mihic SJ, Liu Y, Deitrich RA, Harris RA. Actions of long chain alcohols on GABAA and glutamate recep-tors: relation to in vivo effects. Br J Pharmacol. 1996;118:378-384.
17. Jimi N, Segawa K, Minami K, Sata T, SHigematsu A. Inhibitory effects of the intravenous anesthetic, ketamine, on rat mesangial cell proliferation. Anesth Analg. 1997;84:190-195
18. Bohm M, Schmidt U, Gieschik P, Schwinger RH, Bohm S, Erdmann E. Sensitization of adenylate cyclase by halothane in human myocardium and S49 lymphoma wild-type and cyc- cells: evidence for inactivation of the inhibitory G protein Giα. Mol Pharmacol. 1994;45:380-389.
19. Trimer L, Vulliemoz Y, Woo S-Y, Verosky M. Halotane effect on cAMP generation and hydrolysis in rat brain. Eur J Pharmacol. 1980;66:73-80.
20. Maas JW Jr, Vogt SK, Chan GCK, Pineda VV, Storm DR, Muglia LJ. Calcium-stimulated adenylate cyclase are critical modulators of neuronal ethanol sensitivity. J Neurosci. 2005;25:4118-4126.
21. + channels. Cell Signal. 1997;9:551-573.
22. + channels by GABA-B receptors expressed in Xenopus oocytes. Neuroreport. 1998;9: 583-587.
23. + channels. Re-ceptors Channels. 1999;6:363-374.
24. Weigl LG, Schreibmayer W. G protein-gated inwardly rectifying potassium channels are targets for volatile anesthetics. Mol Pharmacol. 2001;60:282-289.
25. Yamakura T, Lewohl JM, Harris RA. Differential effects of general anesthetics on G protein-coupled inwardly rectifying and other potassium channels. Anesthesiology. 2001;95:144-153.
26. Lewohl JM, Wilson WR, Mayfield RD, Brozowski SJ, Morrisett RA, Harris RA. G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action. Nat Neurosci. 1999;2:1084-1090.
27. Inhibition by ketamine of muscarinic acetylcholine receptor function. Durieux ME. Anesth Analg. 1995;81:57-62.
28. Nagase Y, Kaibara M, Uezono Y, Izumi F, Sumikawa K, Taniyama K. Propofol inhibits muscarinic acetylcholine receptor-mediated signal transduction in Xenopus oocytes expressing the rat M1 re-ceptor. J Pharmacol Sci. 1999;79:319-325.
29. Kovoor A, Celver JP, Wu A, Chavkin C. Agonist induced ho-mologous desensitization of μ-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy. Mol Pharmacol. 1998;54:704-711.
30. Tyrosine phosphorylation of the μ-opioid receptor regulates ago-nist intrinsic efficacy. Mol Pharmacol. 2001;59:1360-1368.
31. Wieber J, Gugler R, Hengstmann JH, Dengler HJ. Pharmacoki-netics of ketamine in man. Anaesthesist. 1975;24:260-263.
32. Idvall J, Ahlgren I, Aronsen KR, Stenberg P. Ketamine infusions: pharmacokinetics and clinical effects. Br J Anaesth. 1979;51:1167-1173.
33. Hirota K, Okawa H, Appadu BL, Grandy DK, Devi LA, Lambert DG. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells. Anesthesiology. 1999;90:174-182.
34. Kirkpatrick T, Cockshott ID, Douglas EJ, Nimmo WS. Pharma-cokinetics of propofol (diprivan) in elderly patients. Br J Anaesth. 1988;60:146-150.
35. Lambert DG, Appadu BL. Muscarinic receptor subtypes: do they have a place in clinical anaesthesia? Br J Anaesth. 1995;74:497-499.
36. Koyama T, Mayahara T, Wakamatsu T, Sora I, Fukuda K. Dele-tion of μ-opioid receptor in mice does not affect the minimum alveolar concentration of volatile anaesthetics and nitrous oxide-induced analgesia. Br J Anaesth. 2009;103:744-749.
37. Oswald LM, Wand GS. Opioids and alcoholism. Physiol Behav. 2004;81:339-358.
38. Herz A. Endogenous opioid systems and alcohol addiction. Psy-chopharmacology (Berl). 1997;129:99-111.
39. Vukojevic V, Ming Y, D'Addario C, Rigler R, Johansson B, Terenius L. Ethanol/naltrexone interactions at the mu-opioid re-ceptor. CLSM/FCS study in live cells. PLoS One. 2008;3:e4008.